A Research Study to Compare Two Different Versions of Injectable CagriSema in People With Type 2 Diabetes

NCT07357740 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

400

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: CagriSema
DRUG: Placebo CagriSema

Sponsor

Novo Nordisk A/S